Biotechnology Amarin Supports Investigator-Initiated Trial at Kaiser Permanente in the U.S. to Study the Effects of VASCEPA® (icosapent ethyl) in Reducing Viral Upper Respiratory Infections, Including COVID-19 and Flu, and the Clinical Severity of Such Infections August 7, 2020
Biotechnology Is BioMarin Pharmaceutical (BMRN) Outperforming Other Medical Stocks This Year? August 7, 2020
Biotechnology Biohaven Announces up to $500 Million Non-Dilutive Term Loan with Sixth Street August 7, 2020
Biotechnology Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million August 7, 2020
Search
Biotechnology
